Casey Graves Joins ConcertAI as GM of Clinical Solutions Team
ConcertAI, a number one supplier of multi-modal knowledge and agentic AI options for all times sciences and healthcare, at this time introduced the appointment of Casey Graves as common supervisor of Clinical Solutions. In this pivotal position, Graves will drive development and innovation in real-world knowledge (RWD) and AI options for oncology analysis and medical care, accelerating advances that enhance outcomes for sufferers and healthcare suppliers.
As common supervisor, Graves will oversee the strategic route of the oncology enterprise, main cross-functional groups in product improvement, knowledge science, medical operations, and business technique. He will drive partnerships throughout the oncology ecosystem, leveraging ConcertAI’s knowledge belongings and AI capabilities to ship impactful options for most cancers analysis and care. Additionally, he’ll lead the CancerLinQ® initiative, solidifying ConcertAI’s management in oncology innovation.
Graves brings in depth expertise in healthcare AI, analytics, and SaaS from management roles at main well being know-how and consulting corporations. Most just lately, he served as a board advisor and guide for healthcare AI software program firms. Prior to that, Graves was the final supervisor of Truven, the Health Insights and MarketScan companies, at Merative, the place he owned a revenue and loss (P&L) of over $200M and executed profitable development and product modernization methods through the transition from IBM Watson Health. He additionally held a number of common supervisor positions at IBM Watson Health, main provider-focused enterprise models and driving modernization and enlargement. Before his time at IBM, Graves served as a companion at Deloitte Consulting, the place he launched AI options for early adopter well being programs, co-founded the Innovation Lab, and led the Healthcare Analytics Practice.
“Casey’s confirmed management in scaling healthcare SaaS options and his deep experience in AI and analytics are an incredible asset to our group,” mentioned Eron Kelly, CEO of ConcertAI. “As the final supervisor of our newly created and mixed enterprise unit overseeing RWE, Clinical Trials, and CancerLinQ, Casey steps into a significant management position. Casey’s imaginative and prescient and expertise can be invaluable as we proceed to boost these choices to ship even larger affect for oncology care groups and the sufferers they serve.”
Graves’ appointment marks a big step as ConcertAI expands its suite of AI-powered options to speed up analysis and enhance affected person outcomes. His mix of business management, scientific understanding, and technological imaginative and prescient can be important in driving the following part of development for the corporate’s medical options, guaranteeing they proceed to make an actual distinction in most cancers analysis and care worldwide.
The put up Casey Graves Joins ConcertAI as GM of Clinical Solutions Team first appeared on AI-Tech Park.
